» Articles » PMID: 7511207

Loss of P53 Protein During Radiation Transformation of Primary Human Mammary Epithelial Cells

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1994 Apr 1
PMID 7511207
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The causative factors leading to breast cancer are largely unknown. Increased incidence of breast cancer following diagnostic or therapeutic radiation suggests that radiation may contribute to mammary oncogenesis. This report describes the in vitro neoplastic transformation of a normal human mammary epithelial cell strain, 76N, by fractionated gamma-irradiation at a clinically used dose (30 Gy). The transformed cells (76R-30) were immortal, had reduced growth factor requirements, and produced tumors in nude mice. Remarkably, the 76R-30 cells completely lacked the p53 tumor suppressor protein. Loss of p53 was due to deletion of the gene on one allele and a 26-bp deletion within the third intron on the second allele which resulted in abnormal splicing out of either the third or fourth exon from the mRNA. PCR with a mutation-specific primer showed that intron 3 mutation was present in irradiated cells before selection for immortal phenotype. 76R-30 cells did not exhibit G1 arrest in response to radiation, indicating a loss of p53-mediated function. Expression of the wild-type p53 gene in 76R-30 cells led to their growth inhibition. Thus, loss of p53 protein appears to have contributed to neoplastic transformation of these cells. This unique model should facilitate analyses of molecular mechanisms of radiation-induced breast cancer and allow identification of p53-regulated cellular genes in breast cells.

Citing Articles

Establishment of a sheep immortalization cell line for generating and amplifying Orf virus recombinants.

Sun S, Zhao K, Lu H, Liu X, Li Y, Li Q Front Vet Sci. 2023; 9:1062908.

PMID: 36619965 PMC: 9813594. DOI: 10.3389/fvets.2022.1062908.


Ionizing Radiation and Estrogen Affecting Growth Factor Genes in an Experimental Breast Cancer Model.

Calaf G, Crispin L, Munoz J, Aguayo F, Roy D, Narayan G Int J Mol Sci. 2022; 23(22).

PMID: 36430763 PMC: 9693528. DOI: 10.3390/ijms232214284.


Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Helm J, Rudel R Arch Toxicol. 2020; 94(5):1511-1549.

PMID: 32399610 PMC: 7261741. DOI: 10.1007/s00204-020-02752-z.


Experimental identification of cancer driver alterations in the era of pan-cancer genomics.

Korenjak M, Zavadil J Cancer Sci. 2019; 110(12):3622-3629.

PMID: 31594033 PMC: 6890429. DOI: 10.1111/cas.14210.


A prospect of cell immortalization combined with matrix microenvironmental optimization strategy for tissue engineering and regeneration.

Wang Y, Chen S, Yan Z, Pei M Cell Biosci. 2019; 9:7.

PMID: 30627420 PMC: 6321683. DOI: 10.1186/s13578-018-0264-9.


References
1.
Hartwell L . Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell. 1992; 71(4):543-6. DOI: 10.1016/0092-8674(92)90586-2. View

2.
Vogelstein B, Kinzler K . p53 function and dysfunction. Cell. 1992; 70(4):523-6. DOI: 10.1016/0092-8674(92)90421-8. View

3.
Kessis T, Slebos R, Nelson W, Kastan M, Plunkett B, Han S . Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci U S A. 1993; 90(9):3988-92. PMC: 46431. DOI: 10.1073/pnas.90.9.3988. View

4.
Krolewski B, Little J . Application of denaturing gradient gel blots to detect p53 mutations in X-ray-transformed mouse C3H 10T1/2 clones. Mol Carcinog. 1993; 7(3):190-6. DOI: 10.1002/mc.2940070309. View

5.
Band V, Dalal S, Delmolino L, Androphy E . Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J. 1993; 12(5):1847-52. PMC: 413405. DOI: 10.1002/j.1460-2075.1993.tb05833.x. View